Japan headquartered Nippon Express Holdings has signed a strategic partnership agreement with Iceland-based Control...
Takeda Pharma has announced that LIVTENCITY (maribavir) has been approved by the Japanese Ministry of Health, ...
Japan-based Healios K.K. has entered into a license agreement with Astellas Institute for Regenerative Medicine (A...
Singapore-based startup Mirxes has announce that its fully-owned subsidiary, Mirxes Japan, has secured a grant of up to ...
Japan-based Shionogi & Co. has entered into an option agreement with French firm Cilcare DEV SAS to acquire the...
Japan-headquartered firm Shimadzu has acquired all shares of Zef Scientific Inc., through its US subsidiary Shimadzu Sci...
Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how...
Asahi Kasei Medical's US subsidiary Bionova Scientific, a full-service biologics CDMO, has decided to launch a new busin...
Fujitsu Japan and Juntendo University have announced the launch of a “Medical Digital Resilience Research Course,&...
Japan-headquartered Shimadzu Corporation has released the LCMS-8060RX, LCMS-8050RX, and LCMS-8045RX triple quadrupole hi...
The consortium of Teijin Limited, Fukui Tateami Co., Ltd., and Osaka Medical and Pharmaceutical University has ann...
A research team at Osaka University, Japan will start an investigator-initiated clinical trial for refractory prostate c...
Asahi Kasei Medical has completed the construction of its third assembly plant for Planova virus removal filters in Nobe...
Japan's Hitachi High-Tech and Swiss firm Roche have extended their partnership, committing to at least 10 years of addit...
Shimadzu Corporation has announced the release of Peakintelligence for LC, software incorporating a proprietary for...
Japan-headquartered Daiichi Sankyo has established two research institutes- DS Research Institute Boston and DS Re...
Eisai Co. and nippon medac Co., a subsidiary of medac group, have launched the anti-rheumatic agent 'Metoject Subcutaneo...
Astellas Pharma Inc. has signed a Memorandum of Understanding (MoU) with Yaskawa Electric Corporation to begin discussio...
